Response Biomedical Announces Insider Participation in Current...( VANCOUVER Oct. 27 / In accordance...),Health

VANCOUVER, Oct. 27 /PRNewswire-FirstCall/ - In accordance with the Rules of the Toronto Stock Exchange, Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) (the "Company") today announced that certain insiders (the "Insiders") of the Company will participate in the financing announced on October 14, 2008 (the "Financing").

As previously announced, the Financing involves the issuance of an aggregate of (up to) 36.67 million units with each unit being offered at a price of $0.15 per unit and consisting of one common share and one half of one share purchase warrant. Each full warrant will entitle the holder to acquire one additional common share of the Company at a price of $0.20 per common share for a period of 36 months from the closing date of the Financing.

The following insiders will be participating in the Financing and will be purchasing such number of units as appears beside their name (representing such percentage of the total number of issued and outstanding common shares prior to this transaction as appears in brackets beside the number of units):

(1) Richard Bastiani (Chairman): 1,333,334 units (approximately 0.98%

excluding any warrant shares and

approximately 1.47% including all

warrant shares)

(2) Richard Bear (Director): 666,600 units (approximately 0.49%

excluding any warrant shares and

approximately 0.73% including all

warrant shares)

(3) Anthony Holler (Director): 1,833,334 units (approximately 1.34%

excluding any warrant shares and

approximately 2.0% including all

warrant shares)

(4) S. Wayne Kay (CEO) : 670,000 units
'/>"/>